Retroclavicular Block in Vascular Surgey

NCT06406712 | Recruiting DMC

• 1 other identifier: new valley anesthesia g2
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

The retroclavicular (coracoid) approach for brachial plexus anesthesia is recognized for its facility and simplicity to perform . The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig . first described the block's use in the ED setting for a variety of indications . Because of its different needle entry point, the retro clavicular (RCB) approach offers an almost perpendicular needle-ultrasound (US) beam angle.

Conditions

Pain Management

Outcome Measures

Primary Outcomes (1)

• sensory and motor duration of block

  efficacy of block

  24 hours

Study Arms (2)

dexamethasone with bupivacaine in retroclavicular block

ACTIVE COMPARATOR

40patients received 40 ml of bupivacaine 0.25%(in total 100 mg)+1 ml of dexamethasone)

Other: retroclavicular block

bupivacaine in retroclavicular block (control group)

ACTIVE COMPARATOR

: 40patients received. 40 ml of bupivacaine 0.25%(in total 100 mg)+1 ml saline

Other: retroclavicular block

Interventions

retroclavicular block OTHER

regional anesthesia

bupivacaine in retroclavicular block (control group); dexamethasone with bupivacaine in retroclavicular block

Eligibility Criteria

• Age: 20 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients undergoing upper limb vascular surgey .

You may not qualify if:

• \- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis).
• Altered conscious level.
• Pregnancy.
• Body mass index (BMI \> 35).
• Patients who have difficulty understanding the study protocol.
• Patients who have any known contraindication to study medications.
• Patient refusal.

Sponsors & Collaborators

• New Valley University: lead

Study Sites (1)

Faculty of Medicine

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• ahmed ismail, lecture

  faculty of medicine , new valley university

  PRINCIPAL INVESTIGATOR

Central Study Contacts

ahmed ismail, lecture

CONTACT

01097845491; ahmed_ismail87@med.nvu.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: lecture of anesthesia and ICU

Study Record Dates

• First Submitted: May 6, 2024
• First Posted: May 9, 2024
• Study Start: June 1, 2024
• Primary Completion: January 1, 2025
• Study Completion: February 1, 2025
• Last Updated: June 5, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)